Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and pulmonary hypertension: a perspective.

M R Nicolls1, L Taraseviciene-Stewart, P R Rai

  • 1Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA. mark.nicolls@uchsc.edu

The European Respiratory Journal
|December 2, 2005
PubMed
Summary

Autoimmunity may drive pulmonary arterial hypertension (PAH) development. Loss of self-tolerance and auto-antibodies targeting endothelial cells could initiate this severe lung disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum for health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry.

Pulmonary circulation·2022
Same author

Aspergillus-related pulmonary diseases in lung transplantation.

Medical mycology·2016
Same author

Simultaneously Targeting Myofibroblast Contractility and Extracellular Matrix Cross-Linking as a Therapeutic Concept in Airway Fibrosis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.

American journal of physiology. Lung cellular and molecular physiology·2016
Same author

Lung Quality and Utilization in Controlled Donation After Circulatory Determination of Death Within the United States.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Reconciling paradigms of abnormal pulmonary blood flow and quasi-malignant cellular alterations in pulmonary arterial hypertension.

Vascular pharmacology·2016

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Pulmonary Medicine

Background:

  • The link between autoimmunity and pulmonary arterial hypertension (PAH) is known, but its specific role in disease development is unclear.
  • Diverse conditions, including infections and connective tissue disorders, can lead to similar pulmonary vascular pathology.
  • Regulatory T-cells' role in preventing B-cell overactivity is a potential unifying biological factor.

Purpose of the Study:

  • To review autoimmune phenomena in PAH patients.
  • To explore if loss of self-tolerance and subsequent autoimmune injury contribute to PAH pathogenesis.
  • To investigate the connection between immune system defects and PAH development.

Main Methods:

  • Review of existing literature on autoimmune diseases and PAH.

Related Experiment Videos

  • Analysis of immune system defects, specifically CD4 T-cells and auto-antibody production, in conditions associated with severe pulmonary hypertension.
  • Examination of the role of auto-antibodies in endothelial cell apoptosis.

    • Main Results:

    • Conditions linked to severe angioproliferative pulmonary hypertension often show CD4 T-cell defects and auto-antibody production.
    • Pathogenic auto-antibodies targeting endothelial cells can induce apoptosis, potentially initiating PAH.
    • A loss of self-tolerance may precede autoimmune injury contributing to PAH.

    Conclusions:

    • Autoimmune processes, including auto-antibody production against endothelial cells, are implicated in PAH development.
    • Defects in immune regulation, particularly involving T-cells, may play a crucial role.
    • Further research into early self-tolerance loss could elucidate PAH's autoimmune origins.